
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid na... Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -1.86335403727 | 3.22 | 3.36 | 3.11 | 791539 | 3.2586049 | CS |
4 | -0.37 | -10.4815864023 | 3.53 | 3.65 | 3.04 | 922370 | 3.29177707 | CS |
12 | 0.06 | 1.93548387097 | 3.1 | 3.725 | 2.94 | 805974 | 3.32142117 | CS |
26 | -0.06 | -1.86335403727 | 3.22 | 3.725 | 2.705 | 899752 | 3.31702064 | CS |
52 | -0.255 | -7.46705710102 | 3.415 | 4.725 | 2.705 | 951943 | 3.58733692 | CS |
156 | 0.33 | 11.6607773852 | 2.83 | 4.725 | 1.69 | 895545 | 2.93124904 | CS |
260 | 1.31 | 70.8108108108 | 1.85 | 9 | 1.6 | 2136311 | 3.7801518 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.